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Student Researcher: Ashlee Blannett
Faculty Mentor: Lorie Zelna, M.S., R.T. (R)(MR)

Introduction

TAVR Definition

The purpose of this project is to explore the
benefits and risks of the transcatheter aortic valve
replacement (TAVR) procedure compared to the
surgical aortic valve replacement (SAVR)
procedure in the treatment of aortic valve stenosis
(AS). TAVR is a lifesaving procedure for patients
who are unable to undergo the surgery to repair
their aortic valve stenosis. Aortic valve stenosis is
a narrowing of the aortic valve of the heart that
causes the valve to not fully open. When the aortic
valve does not fully open this causes a reduction
or blocking of blood flow from the heart into the
aorta causing reduced blood output to the rest of
the body. The equipment and technology used for
TAVR procedures is becoming more advanced
and safer to ensure positive postoperative
outcomes and rapid recovery. This project focuses
on a 78-year-old, male patient who has a history of
cancer, obesity, kidney failure, and is a former
smoker. In May of 2019, he was diagnosed with
severe aortic valve stenosis and underwent a
TAVR procedure. The patient presented in the
emergency department on October 7, 2021, with
chest pain and a syncope episode and had a
cardiac catheterization performed. On October 14,
2021, the patient underwent a TAVR procedure to
readdress the severe aortic stenosis. Without the
second TAVR procedure the patient had a 50%
chance of mortality in 6-12 months.

•The percutaneous replacement of the aortic valve
in the heart through the blood vessels
•less risky of a procedure
•can be done on patients who cannot be
approved for SAVR
•relatively newer procedure than SAVR, only
been around for 10-20 years depending on
the global area

Aortic Valve Stenosis
•Causes reduced blood flow to the rest of the body
•Reduced blood flow to the rest of the body
can cause organ malfunction, muscle
atrophy, and many more serious
complications such as death
•Is the number one leading contributor for patients
needing TAVR procedures
•The risk for aortic stenosis increases with
age
•100% of TAVR procedures are performed
due to severe aortic valve stenosis
•Is a narrowing of the aortic valve, decreases
blood flow through the heart and body
•Valve can’t open fully

Severe aortic stenosis and TAVR. (2021)

SAVR Definition
•Commonly referred to as “open-heart”
•Chest cavity is opened through incisions, and the
diseased aortic valve is replaced
•much more invasive procedure
•has been done for the last 50 years

Patient Demographics and History
• 78-year-old, male patient

SAVR Benefits and Risks
• The benefits of SAVR are:
•Lower risk of paravalvular regurgitation
compared to TAVR
• The risks of SAVR are:
•Higher incidence of death, stroke, and major
adverse cardiac and cerebrovascular events
•Longer and more intense recovery time
(Rosato et al., p. 10, 2021)

Image 2

• History of severe aortic valve stenosis and
TAVR procedure May 2019
• History of cancer, obesity, kidney failure, and a
former smoker.

Patient Diagnosis and Treatment
May 2019
•TAVR procedure performed to repair aortic valve
stenosis
October 7, 2021
•Underwent diagnostic cardiac catheterization
•Coronary arteries clear
•Re-narrowing of aortic valve

(Geisinger Community Medical Center. 2021)
Image 1:
Red circle is highlighting the previously placed aortic valve
replacement during the Cardiac Catheterization procedure where
contrast has filled the left coronary vessels to check for any
possible lesions or blockages
Image 2:
Red circle is highlighting the previously placed aortic valve
replacement during a Cardiac Catheterization procedure where
contrast has filled the right coronary vessel to check for any
possible lesions or blockages

Interventional Procedure: TAVR
October 14, 2021
Image 3

•Treatment planning set-up for TAVR conducted
October 14, 2021
•Underwent interventional TAVR procedure
•Stent was placed in valve
•Balloon inflated and deflated in stent to open
valve while pacer machine kept heart from
normal systolic/diastolic motions
•Pacer machine kept heart from pumping
blood strongly through the heart while stent
was being deployed so the stent did not move
out of optimal position
•Pacer machine turned off
•Balloon removed
•Post-op TAVR imaging demonstrated mild aortic
valve regurgitation

Image 4

(Geisinger Community Medical Center. 2021)
Image 3:
Circle encompasses the new device being brought down in the
aortic valve through the previously placed device

Image 4:
Arrow is pointing to the device balloon being expanded to deploy
the new, secondary aortic valve replacement.

•Patient discharged and prescribed 81 mg of
Aspirin and 75mg of Plavix daily for 3 months
October 28, 2021
•Follow-up appointment revealed:
•no chest pain
•no shortness of breath
•no dizziness
•no syncope
•Improved fatigue on exertion

(Rosato et al., p. 10, 2021)

Image 1

• Symptoms of daily chest pain, shortness of
breath, dizziness, fatigue on exertion, and a
syncope episode

TAVR Benefits and Risks
• The benefits of TAVR are:
•Less invasive procedure
•Shorter recovery time
•Lessened mortality rate
•Less complications
• The risks of TAVR are:
•Severe paravalvular regurgitation
•Permanent pacemaker implantation
•Major vascular complications
“Analysis of patients who underwent transfemoral
TAVR showed that among 939 matched pairs
TAVR was associated with significantly lower risk
of mortality at one year (7.8 vs. 11.7%, HR 0.65,
95% CI 0.48–0.87) compared to SAVR patients”
(Rosato et al., p. 10, 2021)

Diagnostic Procedure: Cardiac Cath
October 7, 2021

Conclusion
Based on the research conducted about TAVR,
this case study demonstrates the importance of
this procedure. Without the second TAVR
procedure performed on the 78-year-old patient,
there was a risk of a 50% mortality rate in the next
6-12 months. This patient’s case was considered
unusual in that a second TAVR procedure was
required. The TAVR procedure has come to be
seen as a safe and valuable option to patients with
aortic valve stenosis.

